MORETTI, MILENA
MORETTI, MILENA
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
From 2-Triethylammonium Ethyl Ether of 4-Stilbenol (MG624) to Selective Small-Molecule Antagonists of Human α9α10 Nicotinic Receptor by Modifications at the Ammonium Ethyl Residue [From 2-Triethylammonium Ethyl Ether of 4-Stilbenol (MG624) to Selective Small-Molecule Antagonists of Human alpha 9 alpha 10 Nicotinic Receptor by Modifications at the Ammonium Ethyl Residue]
2022 F. Bavo, M. Pallavicini, S. Pucci, R. Appiani, A. Giraudo, B. Eaton, L. Lucero, C. Gotti, M. Moretti, P. Whiteaker, C. Bolchi
Choline and nicotine increase glioblastoma cell proliferation by binding and activating α7- and α9- containing nicotinic receptors
2021 S. Pucci, F. Fasoli, M. Moretti, R. Benfante, S. Di Lascio, P. Viani, A. Daga, T.J. Gordon, M. Mcintosh, M. Zoli, F. Clementi, C. Gotti
Behavioural and pharmacological profiles of zebrafish administrated pyrrolidinyl benzodioxanes and prolinol aryl ethers with high affinity for heteromeric nicotinic acetylcholine receptors
2020 D. Braida, L. Ponzoni, M. Moretti, P. Viani, M. Pallavicini, C. Bolchi, R. Appiani, F. Bavo, C. Gotti, M. Sala
Persistent cognitive and affective alterations at late withdrawal stages after long-term intermittent exposure to tobacco smoke or electronic cigarette vapour : Behavioural changes and their neurochemical correlates
2020 L. Ponzoni, D. Braida, L. Carboni, M. Moretti, P. Viani, F. Clementi, M. Zoli, C. Gotti, M. Sala
Modifications at C(5) of 2-(2-Pyrrolidinyl)-Substituted 1,4-Benzodioxane Elicit Potent α4β2 Nicotinic Acetylcholine Receptor Partial Agonism with High Selectivity over the α3β4 Subtype
2020 F. Bavo, M. Pallavicini, C. Gotti, R. Appiani, M. Moretti, S.F. Colombo, S. Pucci, P. Viani, R. Budriesi, M. Renzi, S. Fucile, C. Bolchi
Increased sensitivity to D9-THC-induced rewarding effects after seven-week exposure to electronic and tobacco cigarettes in mice
2019 L. Ponzoni, M. Moretti, D. Braida, M. Zoli, F. Clementi, P. Viani, M. Sala, C. Gotti
Novel N-aryl nicotinamide derivatives: Taking stock on 3,6-diazabicyclo[3.1.1]heptanes as ligands for neuronal acetylcholine receptors
2019 G. Murineddu, C. Gotti, B. Asproni, P. Corona, K. Martinello, S. Plutino, S. Fucile, V. Temml, M. Moretti, P. Viani, D. Schuster, S. Piras, F. Deligia, G.A. Pinna
alpha9- and alpha7-containing receptors mediate the pro-proliferative effects of nicotine in the A549 adenocarcinoma cell line
2018 V. Mucchietto, F.M. Fasoli, P. Susanna, M. Moretti, B. Roberta, A. Maroli, S. DI LASCIO, C. Bolchi, M. Pallavicini, D. Cheryl, M. Michael, F. Clementi, G. Cecilia
Potent Antiglioblastoma Agents by Hybridizing the Onium-Alkyloxy-Stilbene Based Structures of an α7-nAChR, α9-nAChR Antagonist and of a Pro-Oxidant Mitocan
2018 F. Bavo, S. Pucci, F. Fasoli, C. Lammi, M. Moretti, V. Mucchietto, D. Lattuada, P. Viani, C. De Palma, R. Budriesi, I. Corradini, C. Dowell, J.M. Mcintosh, F. Clementi, C. Bolchi, C. Gotti, M. Pallavicini
In vivo study of the role of α6-containing nicotinic acetylcholine receptor in retinal function using subtype-specific RDP-MII(E11R) toxin
2017 D. Barloscio, E. Cerri, L. Domenici, R. Longhi, C. Dallanoce, M. Moretti, A. Vilella, M. Zoli, C. Gotti, N. Origlia
Nicotinic receptors increase cell proliferation and tumour progression in non-small cell lung cancer cell line
2015 V. Mucchietto, F. Fasoli, R. Benfante, A. Maroli, M.G. Cattaneo, F. Pistillo, M. Moretti, C. Bolchi, M. Pallavicini, F. Clementi, C. Gotti
Different physiological and behavioural effects of e-cigarette vapour and cigarette smoke in mice
2015 L. Ponzoni, M. Moretti, M. Sala, F. Fasoli, V. Mucchietto, V. Lucini, G. Cannazza, G. Gallesi, C.N. Castellana, F. Clementi, M. Zoli, C. Gotti, D. Braida
Partial deletion of the nicotinic cholinergic receptor alpha 4 or beta 2 subunit genes changes the acetylcholine sensitivity of receptor-mediated 86Rb+ efflux in cortex and thalamus and alters relative expression of alpha 4 and beta 2 subunits
2008 C. Gotti, M. Moretti, N.M. Meinerz, F. Clementi, A. Gaimarri, A.C. Collins, M.J. Marks
Regulation of neuronal nicotinic receptor traffic and expression
2007 A. Gaimarri, M. Moretti, L. Riganti, A. Zanardi, F. Clementi, C. Gotti
Extremely low-frequency electromagnetic field (ELF-EMF) does not affect the expression of a3, a5 and a7 nicotinic receptor subunit genes in SH-SY5Y neuroblastoma cell line
2006 R.A. Antonini, R. Benfante, C. Gotti, M. Moretti, N. Kuster, J. Schuderer, F. Clementi, D. Fornasari
Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation
2006 Cecilia Gotti, Milena Moretti, Iwo Bohr, Iryna Ziabreva, Silvia Vailati, Renato Longhi, Loredana Riganti, Annalisa Gaimarri, Ian G. McKeith, Robert H. Perry, Dag Aarsland, Jan Petter Larsen, Emanuele Sher, Ruth Beattie, Francesco Clementi, Jennifer A. Court
Expression of nigrostriatal alpha 6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by beta 3 subunit gene deletion
2005 Cecilia Gotti, Milena Moretti, Francesco Clementi, Loredana Riganti, J. Michael McIntosh, Allan C. Collins, Michael J. Marks, Paul Whiteaker
Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice
2003 N. Champtiaux, C. Gotti, M. Cordero-Erausquin, D.J. David, C. Przybylski, C. Lena, F. Clementi, M. Moretti, F.M. Rossi, N. Le Novere, J.M. McIntosh, A.M. Gardier, J.P. Changeux
Developmental expression of heteromericnicotinic receptor subtypes in chick retina
2003 S. Vailati, M. Moretti, R. Longhi, G.E. Rovati, F. Clementi, C. Gotti
Anti-neuronal nicotinic receptor antibodies in MG patients with thymoma
2001 C. Gotti, M. Moretti, R. Mantegazza, D.M.M. Fornasari, T. Tsouloufis, F. Clementi